Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Singleron Biotechnologies

Request full access

Integrating Molecular and Cellular Information for Clinics

Nanjing City, ChinaFounded 2018Biotech & Life Sciences

About Singleron Biotechnologies

Singleron Biotechnologies is an innovative molecular diagnostic company specializing in single cell analysis techniques. The company operates in the biotechnology sector, focusing on clinical diagnosis, drug development, and health management. Singleron's core product is the GEXSCOPE single cell system, which is based on a uniquely designed microfluidic device licensed exclusively from Yale University. This system allows for high throughput single cell multiomics analysis, providing detailed insights into cellular functions and interactions.

Singleron serves a diverse range of clients including research institutions, pharmaceutical companies, and clinical laboratories. The company operates primarily in the fast-growing single cell analysis market, which is driven by the increasing demand for personalized medicine and advanced diagnostic tools.

The business model of Singleron revolves around the sale of its proprietary single cell analysis systems and related consumables. Additionally, the company offers specialized services in single cell analysis, catering to the specific needs of its clients. Revenue is generated through product sales, service contracts, and licensing agreements.

Singleron has a strong team of over 300 full-time employees with diverse expertise, enabling rapid responses to market and customer needs. The company recently completed Series A2 financing, raising close to $30 million to further its growth and innovation efforts.

Source: Dealroom company data

At a glance

Status
Operational
Employees
91
Open positions
None listed
Dealroom signal
78.6/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, KoelnBusiness, science-based
Business model
Manufacturing
Client focus
B2B
Investment activity
1 company, latest Mar 2022
Capital deployed
—
Preferred round
ACQUISITION

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Nov 2021 $100M $400M CDH Investments · ARCH Venture Partners · Firstred Capital · SB China Capital —
SERIES AOther financing Sep 2020 $30M $120M Tencent · ARCH Venture Partners · Lilly Asia Ventures · China Growth Capital —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Singleron Biotechnologies website traffic

Latest recorded traffic for Singleron Biotechnologies is 2.4K monthly website visits, up 7900% over the last three months. Singleron Biotechnologies's team grew 8.3% over the past year.

Latest monthly visits2.4K 3-month web change+7900% 1-year team growth+8.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Singleron Biotechnologies in the Nanjing City ecosystem

Live from Dealroom

The Singleron Biotechnologies office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Sherpa Venture Partners

Series A9 investors entered at this stage

Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
8 countries with
team presence
🇩🇪 Germany46.6%
🇨🇳 China20.6%
🇸🇬 Singapore13.7%
🇺🇸 United States12.3%
🇫🇷 France2.7%
Top 5 of 8 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Singleron Biotechnologies on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Singleron Biotechnologies’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.